688399 硕世生物
已收盘 09-29 15:00:00
资讯
新帖
简况
股市必读：硕世生物新发布《江苏硕世生物科技股份有限公司关于召开2026年半年度业绩说明会的公告》
证券之星 · 02:16
股市必读：硕世生物新发布《江苏硕世生物科技股份有限公司关于召开2026年半年度业绩说明会的公告》
硕世生物（688399）披露2026年半年度业绩说明会安排，9月28日股价下跌2.35%
证券之星 · 09-28 22:30
硕世生物（688399）披露2026年半年度业绩说明会安排，9月28日股价下跌2.35%
股市必读：硕世生物新发布《江苏硕世生物科技股份有限公司关于收到控股股东提请召开临时股东会的函的公告》
证券之星 · 09-28 02:37
股市必读：硕世生物新发布《江苏硕世生物科技股份有限公司关于收到控股股东提请召开临时股东会的函的公告》
硕世生物控制权纷争升级：控股股东提请召开临时股东会以推动董事会换届，现任董事长未在提名名单中
每日经济新闻 · 09-24
硕世生物控制权纷争升级：控股股东提请召开临时股东会以推动董事会换届，现任董事长未在提名名单中
一致行动人“散伙” 谁在争夺硕世生物控制权？
东方财富网 · 09-24
一致行动人“散伙” 谁在争夺硕世生物控制权？
硕世生物(688399.SH)取得两项医疗器械注册证
智通财经 · 09-24
硕世生物(688399.SH)取得两项医疗器械注册证
硕世生物（688399）9月23日主力资金净买入298.92万元
证券之星 · 09-24
硕世生物（688399）9月23日主力资金净买入298.92万元
股市必读：硕世生物新发布《江苏硕世生物科技股份有限公司简式权益变动报告书》
证券之星 · 09-24
股市必读：硕世生物新发布《江苏硕世生物科技股份有限公司简式权益变动报告书》
股市必读：硕世生物新发布《江苏硕世生物科技股份有限公司关于合伙企业变更执行事务合伙人暨股东权益变动的提示性公告》
证券之星 · 09-23
股市必读：硕世生物新发布《江苏硕世生物科技股份有限公司关于合伙企业变更执行事务合伙人暨股东权益变动的提示性公告》
硕世生物（688399）披露董事会延期换届选举公告，9月21日股价上涨5.51%
证券之星 · 09-21
硕世生物（688399）披露董事会延期换届选举公告，9月21日股价上涨5.51%
股市必读：硕世生物（688399）9月16日董秘有最新回复
证券之星 · 09-17
股市必读：硕世生物（688399）9月16日董秘有最新回复
硕世生物：截至2026年9月10日，公司股东总数9,359户
证券之星 · 09-16
硕世生物：截至2026年9月10日，公司股东总数9,359户
每周股票复盘：硕世生物（688399）股东户数增1.72% 户均持股降
证券之星 · 09-06
每周股票复盘：硕世生物（688399）股东户数增1.72% 户均持股降
硕世生物(688399)8月20日股东户数0.94万户，较上期增加1.72%
证券之星 · 09-02
硕世生物(688399)8月20日股东户数0.94万户，较上期增加1.72%
硕世生物：截至2026年8月20日，公司股东总数9,393户
证券之星 · 09-02
硕世生物：截至2026年8月20日，公司股东总数9,393户
每周股票复盘：硕世生物（688399）股东户数下降1.57%
证券之星 · 08-30
每周股票复盘：硕世生物（688399）股东户数下降1.57%
硕世生物(688399)8月10日股东户数0.92万户，较上期减少1.57%
证券之星 · 08-28
硕世生物(688399)8月10日股东户数0.92万户，较上期减少1.57%
股市必读：硕世生物新发布《江苏硕世生物科技股份有限公司关于2026年半年度计提及转回资产减值准备的公告》
证券之星 · 08-28
股市必读：硕世生物新发布《江苏硕世生物科技股份有限公司关于2026年半年度计提及转回资产减值准备的公告》
图解硕世生物中报：第二季度单季净利润同比增长82.35%
证券之星 · 08-28
图解硕世生物中报：第二季度单季净利润同比增长82.35%
每周股票复盘：硕世生物（688399）股东户数减少1.57%，户均持股市值40.01万元
证券之星 · 08-23
每周股票复盘：硕世生物（688399）股东户数减少1.57%，户均持股市值40.01万元
暂无数据
公司概况
公司名称：
江苏硕世生物科技股份有限公司
所属行业：
医药制造业
上市日期：
2019-12-05
主营业务：
江苏硕世生物科技股份有限公司的主营业务是体外诊断试剂、配套检测仪器等体外诊断产品的研发、生产和销售。公司的主要产品是体外诊断试剂、配套检测仪器等体外诊断产品。
发行价格：
46.78
{"stockData":{"symbol":"688399","market":"SH","secType":"STK","nameCN":"硕世生物","latestPrice":26.78,"timestamp":1790665200000,"preClose":26.98,"halted":0,"volume":1321320,"delay":0,"changeRate":-0.0074,"floatShares":124000000,"shares":124000000,"eps":-0.2055,"marketStatus":"已收盘","change":-0.2,"latestTime":"09-29 15:00:00","open":26.98,"high":27.37,"low":26.5,"amount":35530400,"amplitude":0.0322,"askPrice":26.8,"askSize":6,"bidPrice":26.78,"bidSize":10,"shortable":0,"etf":0,"ttmEps":-0.2055,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790731800000},"marketStatusCode":5,"adr":0,"adjPreClose":26.98,"symbolType":"stock_kcb","openAndCloseTimeList":[[1790645400000,1790652600000],[1790658000000,1790665200000]],"highLimit":29.68,"lowLimit":24.28,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":124130147,"isCdr":false,"pbRate":1.13,"roa":"--","roe":"0.67%","epsLYR":-0.49,"committee":0.813084,"marketValue":3324000000,"turnoverRate":0.0106,"status":1,"afterMarket":{"amount":0,"volume":0,"close":26.78,"buyVolume":0,"sellVolume":0,"time":1790667237746,"indexStatus":"已收盘 09-29 15:30:00","preClose":26.98},"floatMarketCap":3324000000},"requestUrl":"/m/hq/s/688399/tweets","defaultTab":"tweets","newsList":[{"id":"2671414562","title":"股市必读：硕世生物新发布《江苏硕世生物科技股份有限公司关于召开2026年半年度业绩说明会的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2671414562","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671414562?lang=zh_cn&edition=full","pubTime":"2026-09-30 02:16","pubTimestamp":1790705770,"startTime":"0","endTime":"0","summary":"截至2026年9月29日收盘，硕世生物报收于26.78元，下跌0.74%，换手率1.06%，成交量1.32万手，成交额3553.04万元。当日关注点交易信息汇总：9月29日主力资金净流出233.1万元，占总成交额6.56%。公司公告汇总：硕世生物将于2026年10月14日16:00-17:00召开2026年半年度业绩说明会，通过上证路演中心网络互动方式举行。投资者可于2026年9月30日至10月13日16:00前通过上证路演中心网站或公司邮箱sssw@s-sbio.com提问。说明会结束后可通过上证路演中心查看会议情况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000002487.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670556862","title":"硕世生物（688399）披露2026年半年度业绩说明会安排，9月28日股价下跌2.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670556862","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670556862?lang=zh_cn&edition=full","pubTime":"2026-09-28 22:30","pubTimestamp":1790605839,"startTime":"0","endTime":"0","summary":"截至2026年9月28日收盘，硕世生物报收于26.98元，较前一交易日下跌2.35%，最新总市值为33.49亿元。该股当日开盘27.51元，最高28.01元，最低26.71元，成交额达4553.41万元，换手率为1.35%。公告显示，公司将于2026年10月14日16:00-17:00通过上证路演中心网络互动方式召开2026年半年度业绩说明会，介绍公司2026年半年度经营成果及财务状况。投资者可于2026年9月30日至10月13日16:00前通过上证路演中心网站或公司邮箱sssw@s-sbio.com提问。说明会结束后可通过上证路演中心查看会议情况。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800035194.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670340906","title":"股市必读：硕世生物新发布《江苏硕世生物科技股份有限公司关于收到控股股东提请召开临时股东会的函的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2670340906","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670340906?lang=zh_cn&edition=full","pubTime":"2026-09-28 02:37","pubTimestamp":1790534230,"startTime":"0","endTime":"0","summary":"公司董事会将对提请函进行核查及审议，并在规定时间内作出是否召开临时股东会的书面反馈。江苏硕世生物科技股份有限公司关于自愿披露取得医疗器械注册证的公告江苏硕世生物科技股份有限公司近日收到国家药品监督管理局签发的两项医疗器械注册证，分别为丙型肝炎病毒核酸检测试剂盒和基孔肯雅病毒核酸检测试剂盒，注册分类均为三类，有效期均至2031年9月23日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800001320.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669499372","title":"硕世生物控制权纷争升级：控股股东提请召开临时股东会以推动董事会换届，现任董事长未在提名名单中","url":"https://stock-news.laohu8.com/highlight/detail?id=2669499372","media":"每日经济新闻","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669499372?lang=zh_cn&edition=full","pubTime":"2026-09-24 22:11","pubTimestamp":1790259060,"startTime":"0","endTime":"0","summary":"值得注意的是，在闰康生物提名的8位候选人中，硕世生物现任董事长王国强、董事梁钶承未在提名名单中。此次闰康生物提请的直接理由是董事会任期届满，董事会组成人员已被动超期任职。硕世生物控股股东、实控人存在发生变更风险控股股东闰康生物此次主动出击，或与房永生表决权刚刚被削弱有关。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-24/doc-inisxxkt8176396.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-24/doc-inisxxkt8176396.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669496886","title":"一致行动人“散伙” 谁在争夺硕世生物控制权？","url":"https://stock-news.laohu8.com/highlight/detail?id=2669496886","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669496886?lang=zh_cn&edition=full","pubTime":"2026-09-24 21:50","pubTimestamp":1790257800,"startTime":"0","endTime":"0","summary":"硕世生物正面临控制权结构动荡的局面。近日，公司发布公告称，股东泰州硕康企业管理咨询合伙企业（有限合伙）（简称“泰州硕康”）、泰州硕源企业管理咨询合伙企业（有限合伙）（简称“泰州硕源”）完成工商变更，执行事务合伙人由公司实际控制人房永生变更为梁钶承。变更完成后，房永生不再控制泰州硕康、泰州硕源。房永生合计控制硕世生物股份比例从32.24%下降为28.43%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://finance.eastmoney.com/news/1354,202609243883915638.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/news/1354,202609243883915638.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669838466","title":"硕世生物(688399.SH)取得两项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2669838466","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669838466?lang=zh_cn&edition=full","pubTime":"2026-09-24 17:17","pubTimestamp":1790241437,"startTime":"0","endTime":"0","summary":"智通财经APP讯，硕世生物(688399.SH)发布公告，公司近日收到国家药品监督管理局签发的医疗器械注册证(体外诊断试剂)，产品名称：丙型肝炎病毒核酸检测试剂盒(荧光PCR法)、基孔肯雅病毒核酸检测试剂盒(荧光PCR法)。上述《医疗器械注册证》的取得，丰富了公司产品种类，扩充了公司在体外诊断领域的布局，不断满足多元化的临床需求，将增强公司综合竞争力，有利于进一步提高公司的市场拓展能力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1500500.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","PTH","IEIH","LGHT","RSPH","HART","BK1574","LNGR","AGNG","159883","BK0239","688399","BK1100","GDOC","MDEV","MEDX","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669432089","title":"硕世生物（688399）9月23日主力资金净买入298.92万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2669432089","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669432089?lang=zh_cn&edition=full","pubTime":"2026-09-24 08:23","pubTimestamp":1790209432,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月23日收盘，硕世生物报收于27.89元，上涨2.16%，换手率2.04%，成交量2.53万手，成交额7022.37万元。近5日资金流向一览见下表：硕世生物融资融券信息显示，融资方面，当日融资买入418.47万元，融资偿还450.75万元，融资净偿还32.28万元。硕世生物主营业务：公司专注于体外诊断试剂、配套检测仪器等体外诊断产品的研发、生产和销售,并拓展到体外检测服务领域,实现“试剂+仪器+服务”的一体化经营模式。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400007817.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669433620","title":"股市必读：硕世生物新发布《江苏硕世生物科技股份有限公司简式权益变动报告书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2669433620","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669433620?lang=zh_cn&edition=full","pubTime":"2026-09-24 02:16","pubTimestamp":1790187372,"startTime":"0","endTime":"0","summary":"公司公告汇总江苏硕世生物科技股份有限公司简式权益变动报告书江苏硕世生物科技股份有限公司发布简式权益变动报告书，因股东泰州硕康、泰州硕源完成工商变更，执行事务合伙人由实际控制人房永生变更为梁钶承，导致房永生不再控制该两家企业，一致行动关系解除，其支配的公司股份表决权比例由32.24%下降至28.43%。信息披露义务人未来12个月内不排除增减持计划。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400002368.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669129753","title":"股市必读：硕世生物新发布《江苏硕世生物科技股份有限公司关于合伙企业变更执行事务合伙人暨股东权益变动的提示性公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2669129753","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669129753?lang=zh_cn&edition=full","pubTime":"2026-09-23 02:02","pubTimestamp":1790100135,"startTime":"0","endTime":"0","summary":"公司公告汇总江苏硕世生物科技股份有限公司关于合伙企业变更执行事务合伙人暨股东权益变动的提示性公告江苏硕世生物科技股份有限公司股东泰州硕康、泰州硕源完成工商变更，执行事务合伙人由房永生变更为梁钶承。房永生已对变更提出异议，若诉讼成功，控制权可能恢复。此外，控股股东闰康生物涉诉，存在被解散风险，可能导致公司控制权变更。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300002441.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669549001","title":"硕世生物（688399）披露董事会延期换届选举公告，9月21日股价上涨5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669549001","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669549001?lang=zh_cn&edition=full","pubTime":"2026-09-21 17:36","pubTimestamp":1789983384,"startTime":"0","endTime":"0","summary":"截至2026年9月21日收盘，硕世生物报收于26.61元，较前一交易日上涨5.51%，最新总市值为33.03亿元。江苏硕世生物科技股份有限公司于近日发布《关于公司董事会延期换届选举的提示性公告》。公告显示，公司第三届董事会于2026年9月19日届满，因换届准备工作尚未完成，董事会换届选举将延期，董事会各专门委员会及高级管理人员任期相应顺延。公司预计延期换届不会对正常经营产生重大影响，并将及时披露后续进展。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100022415.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668987105","title":"股市必读：硕世生物（688399）9月16日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2668987105","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668987105?lang=zh_cn&edition=full","pubTime":"2026-09-17 01:02","pubTimestamp":1789578139,"startTime":"0","endTime":"0","summary":"截至2026年9月16日收盘，硕世生物报收于24.57元，上涨1.78%，换手率0.96%，成交量1.2万手，成交额2912.04万元。董秘最新回复投资者： 请问截止 2026 年 9 月10日公司的股东人数是多少？谢谢董秘： 尊敬的投资者您好，根据中登公司最新下发的股东名册，截至2026年9月10日，公司股东总数9,359户。当日关注点交易信息汇总：9月16日主力资金净流出55.34万元，占总成交额1.9%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091700000574.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667601647","title":"硕世生物：截至2026年9月10日，公司股东总数9,359户","url":"https://stock-news.laohu8.com/highlight/detail?id=2667601647","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667601647?lang=zh_cn&edition=full","pubTime":"2026-09-16 17:27","pubTimestamp":1789550833,"startTime":"0","endTime":"0","summary":"证券之星消息，硕世生物(688399)09月16日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止 2026 年 9 月10日公司的股东人数是多少？谢谢硕世生物回复：尊敬的投资者您好，根据中登公司最新下发的股东名册，截至2026年9月10日，公司股东总数9,359户。感谢您的关注!本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091600027238.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665653366","title":"每周股票复盘：硕世生物（688399）股东户数增1.72% 户均持股降","url":"https://stock-news.laohu8.com/highlight/detail?id=2665653366","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665653366?lang=zh_cn&edition=full","pubTime":"2026-09-06 03:34","pubTimestamp":1788636851,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘，硕世生物报收于26.93元，较上周的28.37元下跌5.08%。本周，硕世生物9月1日盘中最高价报28.27元。9月3日盘中最低价报26.6元。硕世生物当前最新总市值33.43亿元，在医疗器械板块市值排名94/129，在两市A股市值排名4150/5214。本周关注点股本股东变化：股东户数较上期增加1.72%，户均持股数量下降至1.32万股股本股东变化股东户数变动截至2026年8月20日，硕世生物股东户数为9393.0户，较8月10日增加159.0户，增幅1.72%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600001219.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664901188","title":"硕世生物(688399)8月20日股东户数0.94万户，较上期增加1.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664901188","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664901188?lang=zh_cn&edition=full","pubTime":"2026-09-02 17:28","pubTimestamp":1788341322,"startTime":"0","endTime":"0","summary":"证券之星消息，近日硕世生物披露，截至2026年8月20日公司股东户数为9393.0户，较8月10日增加159.0户，增幅为1.72%。在医疗器械行业个股中，硕世生物股东户数低于行业平均水平，截至8月20日，医疗器械行业平均股东户数为2.1万户。从股价来看，2026年8月10日至2026年8月20日，硕世生物区间跌幅为0.37%，在此期间股东户数增加159.0户，增幅为1.72%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200031044.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664892337","title":"硕世生物：截至2026年8月20日，公司股东总数9,393户","url":"https://stock-news.laohu8.com/highlight/detail?id=2664892337","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664892337?lang=zh_cn&edition=full","pubTime":"2026-09-02 15:54","pubTimestamp":1788335648,"startTime":"0","endTime":"0","summary":"证券之星消息，硕世生物(688399)09月02日在投资者关系平台上答复投资者关心的问题。投资者提问：您好，请问公司8月20日收盘的股东人数是多少？谢谢！硕世生物回复：尊敬的投资者您好，根据中登公司下发的股东名册，截至2026年8月20日，公司股东总数9,393户。感谢您的关注!本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200024946.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663446043","title":"每周股票复盘：硕世生物（688399）股东户数下降1.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663446043","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663446043?lang=zh_cn&edition=full","pubTime":"2026-08-30 08:14","pubTimestamp":1788048858,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，硕世生物报收于28.37元，较上周的28.64元下跌0.94%。本周，硕世生物8月28日盘中最高价报29.43元。本周关注点股本股东变化：股东户数较前期减少1.57%，户均持股上升至1.34万股。股本股东变化截至2026年8月10日，硕世生物股东户数为9,234.0户，较7月20日减少147.0户，减幅1.57%。业绩披露要点硕世生物2026年中报显示，上半年主营收入1.47亿元，同比下降16.03%；归母净利润1956.46万元，同比上升390.02%；扣非净利润-1916.78万元，同比上升31.66%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000004204.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662066844","title":"硕世生物(688399)8月10日股东户数0.92万户，较上期减少1.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662066844","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662066844?lang=zh_cn&edition=full","pubTime":"2026-08-28 17:42","pubTimestamp":1787910127,"startTime":"0","endTime":"0","summary":"证券之星消息，近日硕世生物披露，截至2026年8月10日公司股东户数为9234.0户，较7月20日减少147.0户，减幅为1.57%。户均持股数量由上期的1.32万股增加至1.34万股，户均持股市值为40.01万元。在医疗器械行业个股中，硕世生物股东户数低于行业平均水平，截至8月10日，医疗器械行业平均股东户数为2.12万户。根据统计，硕世生物2026年7月20日至2026年8月10日，主力资金净流出7096.56万元，游资资金净流入1981.79万元，散户资金净流入5114.77万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800040782.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662031120","title":"股市必读：硕世生物新发布《江苏硕世生物科技股份有限公司关于2026年半年度计提及转回资产减值准备的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662031120","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662031120?lang=zh_cn&edition=full","pubTime":"2026-08-28 07:26","pubTimestamp":1787873175,"startTime":"0","endTime":"0","summary":"公司公告汇总江苏硕世生物科技股份有限公司关于2026年半年度计提及转回资产减值准备的公告公司于2026年8月26日召开第三届董事会第十七次会议，审议通过《关于2026年半年度计提及转回资产减值准备的议案》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800013788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662087685","title":"图解硕世生物中报：第二季度单季净利润同比增长82.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662087685","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662087685?lang=zh_cn&edition=full","pubTime":"2026-08-28 02:16","pubTimestamp":1787854599,"startTime":"0","endTime":"0","summary":"证券之星消息，硕世生物2026年中报显示，上半年度公司主营收入1.47亿元，同比下降16.03%；归母净利润1956.46万元，同比上升390.02%；扣非净利润-1916.78万元，同比上升31.66%；其中2026年第二季度，公司单季度主营收入6884.29万元，同比下降18.02%；单季度归母净利润-155.77万元，同比上升82.35%；单季度扣非净利润-1515.55万元，同比上升32.54%；负债率20.9%，投资收益420.36万元，财务费用404.68万元，毛利率63.45%。财报数据概要请见下图:本文数据来源于硕世生物2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800005927.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661312214","title":"每周股票复盘：硕世生物（688399）股东户数减少1.57%，户均持股市值40.01万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2661312214","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661312214?lang=zh_cn&edition=full","pubTime":"2026-08-23 03:30","pubTimestamp":1787427032,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘，硕世生物报收于28.64元，较上周的29.95元下跌4.37%。本周，硕世生物8月20日盘中最高价报30.6元。8月19日盘中最低价报28.21元。硕世生物当前最新总市值35.55亿元，在医疗器械板块市值排名92/129，在两市A股市值排名3934/5210。本周关注点股本股东变化：股东户数减少1.57%，户均持股市值达40.01万元股本股东变化股东户数变动截至2026年8月10日，硕世生物股东户数为9234.0户，较7月20日减少147.0户，减幅1.57%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082300000761.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1790716076355,"stockEarnings":[{"period":"1week","weight":-0.019},{"period":"1month","weight":-0.056},{"period":"3month","weight":-0.1274},{"period":"6month","weight":-0.2475},{"period":"1year","weight":-0.3797},{"period":"ytd","weight":-0.4214}],"compareEarnings":[{"period":"1week","weight":-0.0308},{"period":"1month","weight":-0.0308},{"period":"3month","weight":-0.0686},{"period":"6month","weight":-0.0227},{"period":"1year","weight":-0.0083},{"period":"ytd","weight":-0.0349}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江苏硕世生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"9359人(较上一季度减少0.36%)","perCapita":"13263股","listingDate":"2019-12-05","address":"江苏省泰州市海陵区药城大道837号","registeredCapital":"12413万元","survey":" 江苏硕世生物科技股份有限公司的主营业务是体外诊断试剂、配套检测仪器等体外诊断产品的研发、生产和销售。公司的主要产品是体外诊断试剂、配套检测仪器等体外诊断产品。","listedPrice":46.78},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"硕世生物(688399)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供硕世生物(688399)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"硕世生物,688399,硕世生物股票,硕世生物股票老虎,硕世生物股票老虎国际,硕世生物行情,硕世生物股票行情,硕世生物股价,硕世生物股市,硕世生物股票价格,硕世生物股票交易,硕世生物股票购买,硕世生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"硕世生物(688399)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供硕世生物(688399)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}